Patient Perspectives on Treatment Options for Older Women With Hormone Receptor–Positive Breast Cancer
Author(s) -
Ton Wang,
Nicole M. Mott,
Jacquelyn Miller,
Nicholas L. Berlin,
Sarah T. Hawley,
Reshma Jagsi,
Lesly A. Dossett
Publication year - 2020
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2020.17129
Subject(s) - medicine , breast cancer , interquartile range , radiation therapy , hormone therapy , adverse effect , thematic analysis , sentinel lymph node , cancer , gynecology , family medicine , oncology , qualitative research , social science , sociology
Key Points Question What are older women’s perspectives on recommendations for treatment de-escalation for low-risk, early-stage hormone receptor–positive breast cancer? Findings In this qualitative study of 30 participants aged 70 years or older, women expressed skeptical views regarding age-based treatment guidelines, difficulty interpreting the rationale for reducing low-value care to be a favorable rather than poor prognosis, and perceived benefit of some low-value therapies for peace of mind. Meaning Emphasizing an overall favorable prognosis and improving patient education on the risks vs benefits of adjuvant therapies may help reduce overtreatment in older women with early-stage, hormone receptor–positive breast cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom